Recent News

• 02.03.2025 - Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 01.29.2025 - Zentalis Pharmaceuticals Corporate Event
• 01.29.2025 - Zentalis Pharmaceuticals Shares Updated Clinical Data Demonstrating Meaningful Azenosertib Activity in Cyclin E1+, Platinum-Resistant Ovarian Cancer

Recent Filings

• 02.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 02.04.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 02.03.2025 - 144 Report of proposed sale of securities